Zobrazeno 1 - 10
of 91
pro vyhledávání: '"David M Asmuth"'
Autor:
Gregory D Huhn, Moti Ramgopal, Mamta K Jain, Federico Hinestrosa, David M Asmuth, Jihad Slim, Deborah Goldstein, Shauna Applin, Julie H Ryu, Shuping Jiang, Stephanie Cox, Moupali Das, Thai Nguyen-Cleary, David Piontkowsky, Bill Guyer, Lorenzo Rossaro, Richard H Haubrich
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0224875 (2020)
IntroductionGuidelines advocate the treatment of HCV in all HIV/HCV co-infected individuals. The aim of this randomized, open-label study (ClinicalTrials.gov identifier: NCT02707601; https://clinicaltrials.gov/ct2/show/NCT02707601) was to evaluate th
Externí odkaz:
https://doaj.org/article/17f99115a1574511a445b8925d582138
Autor:
Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, Netanya S Utay, Tae Wook-Chun, Surinder Mann, Angela D Kashuba, Basile Siewe, Anthony Albanese, Paolo Troia-Cancio, Elizabeth Sinclair, Anoma Somasunderam, Tammy Yotter, Steven G Deeks, Alan Landay, Richard B Pollard, Christopher J Miller, Santiago Moreno, David M Asmuth
Publikováno v:
PLoS Pathogens, Vol 13, Iss 5, p e1006368 (2017)
[This corrects the article DOI: 10.1371/journal.ppat.1005381.].
Externí odkaz:
https://doaj.org/article/b4a1aa6644d042a4b9efefd5e7c4b9ac
Autor:
Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, Netanya S Utay, Tae-Wook Chun, Surinder Mann, Angela D Kashuba, Basile Siewe, Anthony Albanese, Paolo Troia-Cancio, Elizabeth Sinclair, Anoma Somasunderam, Tammy Yotter, Steven G Deeks, Alan Landay, Richard B Pollard, Christopher J Miller, Santiago Moreno, David M Asmuth
Publikováno v:
PLoS Pathogens, Vol 12, Iss 3, p e1005540 (2016)
Externí odkaz:
https://doaj.org/article/a6ef1c1428e54acb94946b04ab45ba3c
Autor:
Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, Netanya S Utay, Tae-Wook Chun, Surinder Mann, Angela D Kashuba, Basile Siewe, Anthony Albanese, Paolo Troia-Cancio, Elizabeth Sinclair, Anoma Somasunderam, Tammy Yotter, Steven G Deeks, Alan Landay, Richard B Pollard, Christopher J Miller, Santiago Moreno, David M Asmuth
Publikováno v:
PLoS Pathogens, Vol 12, Iss 1, p e1005381 (2016)
Whether initiation of antiretroviral therapy (ART) regimens aimed at achieving greater concentrations within gut associated lymphoid tissue (GALT) impacts the level of mucosal immune reconstitution, inflammatory markers and the viral reservoir remain
Externí odkaz:
https://doaj.org/article/4c8ddb8fc36e4a4592983eaa38e14cda
Autor:
Mark W Tenforde, Nikhil Gupte, David W Dowdy, David M Asmuth, Ashwin Balagopal, Richard B Pollard, Patcharaphan Sugandhavesa, Javier R Lama, Sandy Pillay, Sandra W Cardoso, Jyoti Pawar, Breno Santos, Cynthia Riviere, Noluthando Mwelase, Cecilia Kanyama, Johnstone Kumwenda, James G Hakim, Nagalingeswaran Kumarasamy, Robert Bollinger, Richard D Semba, Thomas B Campbell, Amita Gupta, ACTG PEARLS and NWCS 319 Study Group
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117424 (2015)
OBJECTIVE:The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. DESIGN:Nested case-control study (n = 332) within ACTG PEARLS trial
Externí odkaz:
https://doaj.org/article/7846c2a4c66a479997e5e3fb2bed1f56
Autor:
Onyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, Laura C Salazar, Keith Henry, David M Asmuth, David Wohl, Richard Gilson, Yongwu Shao, Ramin Ebrahimi, Stephanie Cox, Alexander Kintu, Christoph Carter, Moupali Das, Jared M Baeten, Diana M Brainard, Gary Whitlock, Jason M Brunetta, Gitte Kronborg, Christoph D Spinner, Andrea Antinori, Vanessa Apea, David Asmuth, Ann Avery, Paul Benson, Colm Bergin, Mezgebe Berhe, Indira Brar, Cynthia Brinson, Jason Brunetta, Jeffrey Burack, Thomas Campbell, Michelle Cespedes, Amanda Clarke, Megan Coleman, Josep Coll, Manuel Crespo Casal, Catherine Creticos, Gordon Crofoot, Frederick Cruickshank, Eric Cua, Eric Daar, Joseph de Wet, Edwin DeJesus, Jorge Del Romero Guerrero, William Dinges, Susanne Doblecki-Lewis, Taylor Donovan, Olamide Dosekun, Jason Flamm, Joel Gallant, Jan Gerstoft, Jay Gladstein, Robert Grant, Robert Grossberg, Bernhard Haas, Jason Halperin, W. David Hardy, Charles Hare, Shawn Hassler, Richard Hengel, William Henry, Theo Hodge, Sybil Hosek, Christopher Hurt, Michelle Iandiorio, Heiko Jessen, Stephen Kegg, Gabriele Knecht, Ivanka Krznaric, Anthony LaMarca, Carsten Schade Larsen, Olav Ditlevsen Larsen, Adriano Lazzarin, Clifford Leen, Christopher Lucasti, Patrick Mallon, Sharon Mannheimer, Martin Markowitz, Claudia Martorell, Kenneth Mayer, Anthony Mills, Jean-Michel Molina, Sheldon Morris, Karam Mounzer, Nneka Nwokolo, Olayemi Osiyemi, Andrew Petroll, Patrick Philibert, John Phoenix, Gilles Pialoux, Frank Post, Maria Prins, Moti Ramgopal, Bruce Rashbaum, Iain Reeves, Gary Richmond, Armin Rieger, Peter Ruane, Laura Salazar, Anthony Scarsella, Gabriel Schembri, Mia Scott, Peter Shalit, Gary Sinclair, Magdalena Sobieszczyk, Christoph Spinner, Jeffrey Stephens, Jason Szabo, Stephen Taylor, Melanie Thompson, Cecile Tremblay, Benoit Trottier, Gene Voskuhl, Barbara Wade, Kimberly Workowski, Sigal Yawetz, Benjamin Young
Publikováno v:
The Lancet HIV, 8(7), e397-e407. Elsevier Limited
DISCOVER study team 2021, ' Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis : week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet HIV, vol. 8, no. 7, pp. e397-e407 . https://doi.org/10.1016/S2352-3018(21)00071-0
DISCOVER study team 2021, ' Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis : week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet HIV, vol. 8, no. 7, pp. e397-e407 . https://doi.org/10.1016/S2352-3018(21)00071-0
Summary Background In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate showed non-inferior efficacy for HIV prevention and improved bone mine
Autor:
David M. Asmuth, Giulia Marchetti
Publikováno v:
AIDS. 35:1691-1693
Autor:
Moises Contreras, Shahin Gharakhanian, Netanya S. Utay, David M. Asmuth, Christopher J. Detzel, Christopher D. Warner
Publikováno v:
Drug development research. 82(7)
COVID-19 manifests as a mild disease in most people but can progress to severe disease in nearly 20% of individuals. Disease progression is likely driven by a cytokine storm, either directly stimulated by SARS-CoV-2 or by increased systemic inflammat
Autor:
Sandra W. Cardoso, Fatima Zulu, Javier R. Lama, Jyoti Pawar, Thomas B. Campbell, Nikhil Gupte, Actg Pearls Study Team, Breno Santos, Amita Gupta, Richard B. Pollard, Nagalingeswaran Kumarasamy, Jonathan E. Golub, Cynthia Riviere, David M. Asmuth, Erin R. Ewald, Khuanchai Supparatpinyo, Umesh G. Lalloo, Nwcs, Cecilia Kanyama, Rupak Shivakoti, Barbara Detrick, Sharlaa Badal-Faesen, James Hakim, Ashwin Balagopal, Richard D. Semba, Wei-Teng Yang
Publikováno v:
Clin Nutr
Summary Background & aims Nutritional deficiency and inflammation may impact CD4+ T cell recovery during combination antiretroviral therapy (cART), particularly in resource-limited settings where malnutrition is prevalent. The aim of this study was t
Autor:
David M. Asmuth, Stephanie Cox, Jason Brunetta, Ramin Ebrahimi, Laura C. Salazar, Jared M. Baeten, Christoph C Carter, Gitte Kronborg, Yongwu Shao, Alexander Kintu, Christoph D. Spinner, Discover Study Team, Gary Whitlock, Moupali Das, Daniel Podzamczer, Keith Henry, Peter Ruane, Diana M. Brainard, Richard Gilson, Onyema Ogbuagu, David A. Wohl
Publikováno v:
SSRN Electronic Journal.
Background: In DISCOVER, a multinational randomized controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate demonstrated noninferior efficacy for HIV prevention and improved bone mineral